Ascletis Pharma Inc announces the approval for ASC22 to conduct clinical trials in chronic hepatitis B patients in China from...
Read more
AstraZeneca’s Lokelma has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in...
Read more
Aquestive Therapeutics, a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, announced that Exservan...
Read more
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency'sCommittee for Medicinal Products for Human Use (CHMP) has adopted...
Read more
Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing innovative drug products, announced that Aucta Pharmaceuticals' New...
Read more
Vesselon (www.vesselon.com) an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent. Vesselon will use Imagent to create...
Read more
GlaxoSmithKline announced that the European Commission has granted marketing authorisation for two new methods of administering Nucala (mepolizumab): a pre-filled...
Read more
IBM and Walmart announced that the companies have been selected by the US FDA to be included in a program...
Read more
Celgene has announced that the US FDA has approved Revlimid (lenalidomide) in combination with rituximab (R2) for patients with previously...
Read more
Pfizer Inc. announced the United States (U.S.) Food and Drug Administration (FDA) has approved TRAZIMERA„¢ (trastuzumab-qyyp), a biosimilar to Herceptin...
Read moreLatest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
